skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Pexastimogene-devacirepvec (Code C71533)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Pexastimogene-devacirepvec

Definition: A thymidine kinase-deleted vaccinia virus expressing human GM-CSF (hGM-CSF) with oncolytic activity. Upon intratumoral or intravenous administration, pexastimogene-devacirepvec may selectively infect and lyse tumor cells. While vaccinia displays a natural tumor cell tropism, deletion of the thymidine kinase gene increases the tumor selectivity of vaccinia by limiting viral replication to transformed cells. hGM-CSF expression by this agent may help recruit antigen processing cells (APCs), such as denritic cells and macrophages, to virally infected tumor cells, initiating a systemic antitumoral immune response.

Display Name: Pexastimogene-devacirepvec

Label: Pexastimogene-devacirepvec

NCI Thesaurus Code: C71533 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL378156  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Thymidine Kinase-(-) Vaccinia-GM-CSF JX-594 Vaccine

External Source Codes: 
CAS Registry Number 1058624-46-6 (see NLM ChemIDplus info)
PDQ Closed Trial Search ID 579292
PDQ Open Trial Search ID 579292 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C71533
Contributing_Source CTRP
Legacy_Concept_Name Thymidine_Kinase-Deleted_Vaccinia-GM-CSF_JX-594_Vaccine
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom